SCHEMBL3276552

SCHEMBL3276552

CCOC(=O)c1cc2ccccc2n1Cc1cccc2ccc(F)cc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOD2 Q9HC29 6/20 0.59
NOD1 Q9Y239 6/20 0.59
F10 P00742 5/20 0.57
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
KDM4E B2RXH2 4/20 0.52
CRHBP P24387 1/20 0.52
CRHR2 Q13324 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
MAPT P10636 4/20 0.48
TDP1 Q9NUW8 2/20 0.48
TSHR P16473 1/20 0.48
RECQL P46063 1/20 0.48
HSD17B10 Q99714 1/20 0.48
ALDH1A1 P00352 3/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
F2 P00734 1/20 0.45
POLB P06746 1/20 0.45
HTT P42858 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3283484 0.91 NOD2 (0.53) NOD2NOD1F10MEN1KMT2A
SCHEMBL3276789 0.89 NOD2 (0.54) NOD2NOD1F10MEN1KMT2A
SCHEMBL3276167 0.89 NOD2 (0.49) NOD2NOD1F10MEN1KMT2A
SCHEMBL3275247 0.88 KMT2A (0.46) NOD2NOD1F10MEN1KMT2A
SCHEMBL3276117 0.84 CCR2 (0.58) F10MEN1KMT2AALDH1A1L3MBTL1
SCHEMBL6706704 0.82 NOD2 (0.82) NOD2NOD1F10MEN1KMT2A
SCHEMBL3276375 0.81 KMT2A (0.73) NOD2NOD1MEN1KMT2AKDM4E
SCHEMBL21822412 0.81 NOD2 (0.54) NOD2NOD1F10MEN1KMT2A
SCHEMBL3277223 0.80 KMT2A (0.53) NOD2NOD1F10MEN1KMT2A
SCHEMBL3275946 0.80 NOD2 (0.64) NOD2NOD1F10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966134-B1 NOVEL FUSED PYRROLE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-12 EP disclosed
US-7696240-B2 Fused pyrrole derivatives HOFFMANN-LA ROCHE INC. (US) 2010-04-13 US disclosed
EP-1966134-A1 NOVEL FUSED PYRROLE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-09-10 EP disclosed
WO-2007068621-A1 NOVEL FUSED PYRROLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-06-21 WO disclosed
US-20070142452-A1 Fused pyrrole derivatives HOFFMANN-LA ROCHE INC. 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142452-A1 Fused pyrrole derivatives CMA1, PREP, CPA3 NOD2 2273/4885NOD1 2866/4885F10 881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.